Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Radiation for Cutaneous Head and Neck Cancer
NCT01979211Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Oct 2013
- Primary completion
- Jan 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in cutaneous squamous cell carcinoma (cSCC), sponsored by University of Cincinnati. Started Oct 2013; status: completed.
02
Drugs
KL-140
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT01979211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979211.